Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Determine the Dermatological Safety and Sensitizing Potential of HAT1 Topical Products Using Cumulative Irritation, Phototoxicity, and Repeated Insult Patch Tests

NCT03406117 is registered in ClinicalTrials.gov with Haus Bioceuticals as lead sponsor.

NCT NCT03406117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03406117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Determine the Dermatological Safety and Sensitizing Potential of HAT1 Topical Products Using Cumulative Irritation, Phototoxicity, and Repeated Insult Patch Tests
Lead sponsor
Haus Bioceuticals
Phase
Phase 4
Overall status
Completed
Start date
April 1, 2016
Completion date
July 21, 2016
Enrollment
182 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, healthy, psoriasis